CHINA RESOURCES DOUBLE-CRANE PHARMACEUTICAL CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.77 CNY | +2.01% |
|
+2.69% | +17.04% |
| Apr. 26 | CR Double-Crane Pharmaceutical's Profit Rises 11% in Q1 as Revenue Grows 2% | MT |
| Apr. 26 | CR Double-Crane Pharmaceutical's Unit Gets Nod to Trial New Pain Medication | MT |
Evolution of the average Target Price on China Resources Double-Crane Pharmaceutical Co.,Ltd.
Price target over the last 5 years
History of analyst recommendation changes
5eb53fbedb1d.i19GzshHz1sMl1JQ9seIb6PJEVjw0QLwSZDH9ieXg0A.uDB2p4lzlixk3SEflaTdKvSTdzqipmDJE8eItHihtTbdawOquHO_FTX6IQ~c2ab8ac327437381d5528f414fa2cbed
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
21.77
CNY
Average target price
25.58
CNY
Spread / Average Target
+17.50%
High Price Target
26
CNY
Spread / Highest target
+19.43%
Low Price Target
25
CNY
Spread / Lowest Target
+14.84%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
B-
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- 600062 Stock
- Consensus China Resources Double-Crane Pharmaceutical Co.,Ltd.
